Shareholders Equity: The sum of preferred and common equity items.
KALA BIO, Inc. (KALA) had Shareholders Equity of $7.00M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-26.98M |
|
-- |
|
-- |
|
$39.16M |
|
$-39.16M |
|
$12.18M |
|
$-26.98M |
|
$-26.98M |
|
$-26.98M |
|
$-26.98M |
|
$-26.98M |
|
$-26.98M |
|
$-39.16M |
|
$-39.51M |
|
8.15M |
|
8.15M |
|
$-3.31 |
|
$-3.31 |
|
| Balance Sheet Financials | |
$9.49M |
|
-- |
|
-- |
|
$9.49M |
|
$2.49M |
|
-- |
|
-- |
|
$2.49M |
|
$7.00M |
|
$7.00M |
|
|
Shareholders Equity |
$7.00M |
27.85M |
|
| Cash Flow Statement Financials | |
$-31.99M |
|
$-0.01M |
|
$-11.62M |
|
$51.18M |
|
$7.56M |
|
$-43.62M |
|
$8.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-32.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-385.70% |
|
-385.65% |
|
-284.30% |
|
-385.65% |
|
$0.25 |
|
$-3.93 |
|
$-3.93 |
|